Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rupa Joshi

Showing results (21-30 of 40) with videos related to

Pageof 4
Sort By:
Indian Journal of Pharmacology|November 6, 2023
Study of fingolimod, nitric oxide inhibitor, and P-glycoprotein inhibitor in modulating the P-glycoprotein expression via an endothelin-sphingolipid pathway in an animal model of pharmacoresistant epilepsyNitika Garg, Rupa Joshi, Alka Bhatia, et al.
Clinical and Experimental Pharmacology & Physiology|February 1, 2024
SEW2871 reduces seizures via the sphingosine 1-phosphate receptor-1 pathway in the pentylenetetrazol and phenobarbitone kindling model of drug-refractory epilepsyAshish Jain, Arti Ralta, Gitika Batra, et al.
ACS Chemical Neuroscience|April 29, 2021
Inhibition of the ERK1/2 Phosphorylation by Dextromethorphan Protects against Core Autistic Symptoms in VPA Induced Autistic Rats: <i>In Silico</i> and <i>in Vivo</i> Drug Repurposition StudyRubal Singla, Abhishek Mishra, Rupa Joshi, et al.
Epilepsia|January 26, 2013
Applicability of the new ILAE classification for epilepsies (2010) in persons with epilepsy at a tertiary care center in IndiaAshwani K Uttam, Rupa Joshi, Rekha Dwivedi, et al.
Veterinary Research Communications|September 14, 2020
Human animal interface of SARS-CoV-2 (COVID-19) transmission: a critical appraisal of scientific evidenceRubal Singla, Abhishek Mishra, Rupa Joshi, et al.
Virologica Sinica|July 2, 2020
A Comprehensive Review of Animal Models for Coronaviruses: SARS-CoV-2, SARS-CoV, and MERS-CoVAshutosh Singh, Rahul Soloman Singh, Phulen Sarma, et al.
ACS Chemical Neuroscience|September 27, 2022
Granulocyte Colony-Stimulating Factor Improved Core Symptoms of Autism Spectrum Disorder via Modulating Glutamatergic Receptors in the Prefrontal Cortex and Hippocampus of Rat BrainsAbhishek Mishra, Rubal Singla, Rohit Kumar, et al.
Fundamental & Clinical Pharmacology|March 30, 2021
Everolimus: A potential therapeutic agent targeting PI3K/Akt pathway in brain insulin system dysfunction and associated neurobehavioral deficitsSeema Bansal, Madhunika Agrawal, Saniya Mahendiratta, et al.
Brain Research Bulletin|March 8, 2021
Role of protein tyrosine phosphatase 1B inhibitor in central insulin resistance and associated cognitive deficitsSeema Bansal, Saniya Mahendiratta, Madhunika Agrawal, et al.
Indian Journal of Pharmacology|May 13, 2022
A preliminary study to evaluate the behavior of Indian population toward E-pharmacySeema Bansal, Hardeep Kaur, Saniya Mahendiratta, et al.
Pageof 4

Showing results (21-30 of 40) with videos related to

Sort By:
Pageof 4
Indian Journal of Pharmacology|November 6, 2023
Study of fingolimod, nitric oxide inhibitor, and P-glycoprotein inhibitor in modulating the P-glycoprotein expression via an endothelin-sphingolipid pathway in an animal model of pharmacoresistant epilepsyNitika Garg, Rupa Joshi, Alka Bhatia, et al.
Clinical and Experimental Pharmacology & Physiology|February 1, 2024
SEW2871 reduces seizures via the sphingosine 1-phosphate receptor-1 pathway in the pentylenetetrazol and phenobarbitone kindling model of drug-refractory epilepsyAshish Jain, Arti Ralta, Gitika Batra, et al.
ACS Chemical Neuroscience|April 29, 2021
Inhibition of the ERK1/2 Phosphorylation by Dextromethorphan Protects against Core Autistic Symptoms in VPA Induced Autistic Rats: <i>In Silico</i> and <i>in Vivo</i> Drug Repurposition StudyRubal Singla, Abhishek Mishra, Rupa Joshi, et al.
Epilepsia|January 26, 2013
Applicability of the new ILAE classification for epilepsies (2010) in persons with epilepsy at a tertiary care center in IndiaAshwani K Uttam, Rupa Joshi, Rekha Dwivedi, et al.
Veterinary Research Communications|September 14, 2020
Human animal interface of SARS-CoV-2 (COVID-19) transmission: a critical appraisal of scientific evidenceRubal Singla, Abhishek Mishra, Rupa Joshi, et al.
Virologica Sinica|July 2, 2020
A Comprehensive Review of Animal Models for Coronaviruses: SARS-CoV-2, SARS-CoV, and MERS-CoVAshutosh Singh, Rahul Soloman Singh, Phulen Sarma, et al.
ACS Chemical Neuroscience|September 27, 2022
Granulocyte Colony-Stimulating Factor Improved Core Symptoms of Autism Spectrum Disorder via Modulating Glutamatergic Receptors in the Prefrontal Cortex and Hippocampus of Rat BrainsAbhishek Mishra, Rubal Singla, Rohit Kumar, et al.
Fundamental & Clinical Pharmacology|March 30, 2021
Everolimus: A potential therapeutic agent targeting PI3K/Akt pathway in brain insulin system dysfunction and associated neurobehavioral deficitsSeema Bansal, Madhunika Agrawal, Saniya Mahendiratta, et al.
Brain Research Bulletin|March 8, 2021
Role of protein tyrosine phosphatase 1B inhibitor in central insulin resistance and associated cognitive deficitsSeema Bansal, Saniya Mahendiratta, Madhunika Agrawal, et al.
Indian Journal of Pharmacology|May 13, 2022
A preliminary study to evaluate the behavior of Indian population toward E-pharmacySeema Bansal, Hardeep Kaur, Saniya Mahendiratta, et al.
Pageof 4